Your research cart is empty.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.
Where molecular science meets editorial precision. Next-gen research peptides — curated, documented, and verified for the researchers who refuse to compromise.
Evo Amino was conceived at the intersection of two worlds: the rigorous analytical standards of modern biochemistry and the design sensibility of luxury editorial brands. The research peptide market was dominated by utilitarian suppliers — functional, but aesthetically indifferent and documentationally sparse.
We saw an opportunity to do something different. Not just better compounds — though that was non-negotiable — but a fundamentally different experience for researchers who care about both the science they're sourcing and the brand they're trusting to deliver it. Every compound in our catalog is accompanied by molecular-level documentation, peer-reviewed citations, and batch-specific analytical data. Because researchers deserve more than a label and a promise.
We are US-based. We are third-party tested. We publish our Certificates of Analysis. And we built an interface worthy of the science inside every vial. That's the Evo Amino thesis — and we're not done building it.
Every compound undergoes a multi-stage analytical verification process before release. This isn't a differentiator — it's the floor. What we build on top of it is what actually matters.
Reverse-phase High-Performance Liquid Chromatography separates each compound by hydrophobicity, generating a chromatogram where purity is calculated as target peak area over total peak area. UV detection at 214 nm captures peptide bond absorbance — no guesswork, only data. Every batch must meet or exceed 99% before it leaves the facility.
LC-MS/MS analysis confirms molecular weight through electrospray ionization and mass-to-charge ratio measurement. Observed mass is compared against theoretical values within ±0.5 Da tolerance. It tells you what the compound actually is — not just how pure it appears. Identity and purity, verified independently.
Limulus Amebocyte Lysate (LAL) testing ensures endotoxin levels meet research-grade thresholds for cell culture applications. For work where even trace bacterial contamination would confound results, this isn't optional — it's the standard.
Every batch ships with a Certificate of Analysis documenting HPLC purity, LC-MS identity confirmation, endotoxin results, batch number, and testing dates. Not a generic specification sheet — a batch-specific record you can cite, archive, and stand behind.
Evo Amino operates from facilities designed for research compound handling and distribution. Climate-controlled storage maintains -20°C for long-term compound preservation. Clean packaging environments and laboratory-grade weighing equipment ensure every vial leaves in the condition it should arrive.
Analytical verification is performed by ISO 17025 accredited third-party laboratories operating under Good Laboratory Practice guidelines — entirely independent of our synthesis partners. Published analytical standards confirm that third-party testing provides unbiased quality verification free from supplier influence (PMID: 19549937). Separation of synthesis and testing is not optional for us.
All operations comply with applicable regulations for research chemical distribution. Compounds are labeled, documented, and sold exclusively for laboratory research use.
Every product page includes detailed scientific documentation: molecular formula, molecular weight, CAS number, amino acid sequence, receptor targets, and mechanisms of action drawn from peer-reviewed literature. We cite PubMed identifiers for every scientific claim — because any claim without a citation is marketing, not science.
This is what separates Evo Amino. Where competitors offer catalog breadth, we offer depth — molecular-level detail that supports serious research. Where competitors provide minimal documentation, we publish batch-specific Certificates of Analysis with every order. Published research confirms that HPLC chromatograms and mass spectra are essential for verifying compound identity and purity prior to experimental use (PMID: 25342275). We treat that as a baseline, not a selling point.
Evo Amino applies a minimum ≥99% purity standard to all research peptides, verified by reverse-phase HPLC with UV detection at 214 nm. This threshold ensures that fewer than 1% of sample content consists of synthesis-related impurities — truncated sequences, oxidized variants, residual reagents. Published research confirms that purity at this level is required for reproducible results in receptor binding assays and cell culture studies (PMID: 19549937). Batches failing to meet the ≥99% specification are rejected. Researchers receive the actual purity percentage on the batch-specific Certificate of Analysis, not a marketing claim. This commitment to documented, measurable purity distinguishes Evo Amino from suppliers who don't disclose analytical methodology.
Two complementary analytical methods for every compound: HPLC for purity quantification and LC-MS for molecular identity confirmation. HPLC separates peptide components based on hydrophobicity; LC-MS confirms molecular weight through electrospray ionization. Both methods are performed by ISO 17025 accredited third-party laboratories, independent of the synthesis supplier. Published analytical guidelines establish this dual-method approach as the standard for research peptide characterization (PMID: 25342275). Endotoxin testing via LAL assay is also performed for compounds intended for cell culture applications. All results appear on the Certificate of Analysis provided with every batch.
HPLC quantifies purity by measuring the proportion of the target compound peak relative to all detected peaks — it tells you how much of the sample is the intended peptide. Mass spectrometry confirms molecular identity by measuring mass-to-charge ratio — it tells you what the compound is. A peptide could show high HPLC purity but still be the wrong compound if synthesis produced a structurally similar impurity. Conversely, a peptide could have correct mass but low HPLC purity due to multiple co-eluting variants. Published guidelines emphasize that both tests are required for complete compound characterization (PMID: 19549937). Evo Amino requires both before releasing any batch.
Each order includes a batch-specific Certificate of Analysis documenting the complete analytical record for that production lot: compound name, CAS number, molecular formula, molecular weight, amino acid sequence, HPLC purity with chromatogram, LC-MS identity confirmation with observed versus theoretical mass, and endotoxin results where applicable. Batch number and testing dates enable full traceability from vial to analytical record. Published quality standards establish CoA documentation as the primary mechanism for research compound traceability (PMID: 30915550). Product pages also include peer-reviewed PMID citations for molecular mechanisms and receptor interactions.
Evo Amino serves the research community exclusively. We do not provide medical advice, therapeutic guidance, or clinical consultations. Our compounds are sold strictly for laboratory research use, and we maintain rigorous editorial standards around content — no therapeutic framing, no human-use implications, no exceptions.
Quality research requires quality compounds. Quality compounds require transparency. Our commitment is to supply researchers with the materials and documentation they need to conduct rigorous, reproducible science — and to do it with the precision and intentionality the discipline demands.
Research Use Only: All compounds sold by Evo Amino are intended exclusively for laboratory research. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Must be 21+ to purchase.
Reach our research support team for inquiries about specific compounds, CoA requests, or institutional pricing.
Contact Us